{'fraction_non_alphanumeric': 0.01812366737739872, 'fraction_numerical': 0.0, 'mean_word_length': 5.26, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
A commercial market for organs? Why not?


 Manga examines the issues surrounding controversial proposals to commercialize organ procurement as a means of reducing the shortage of organs for transplantation. He begins by attempting to define the term "commercialization." Then he discusses the ethical issues of a market approach to organ procurement: the exploitation of the poor, especially in the Third World; the potential negative effect on voluntary donation; the right to dispose of a body or its parts as private property; the question of justice in access to organs; the quality of purchased organs; and the overall social implications of a policy that allows or even encourages the buying and selling of a desperately-needed medical resource. Manga next considers alternative solutions to increasing the supply of organs, and recommends a strategy that could alleviate the organ shortage without resorting to commercialization.
